Spatial and temporal clonal evolution during development of metastatic urothelial carcinoma

Molecular Oncology

Volumn 10, Issue 9, 2016, Pages 1450-1460

  Thomsen, Mathilde B H ^a   Nordentoft, Iver ^a   Lamy, Philippe ^a   Høyer, Søren ^a   Vang, Søren ^a   Hedegaard, Jakob ^a   Borre, Michael ^a   Jensen, Jørgen B ^a   Ørntoft, Torben F ^a   Dyrskjøt, Lars ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Bladder cancer; Clonal evolution; Intra tumour heterogeneity; Metastasis; Targeted therapy; Whole exome sequencing

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; DNA; APOLIPOPROTEIN B MRNA EDITING ENZYME CATALYTIC POLYPEPTIDE LIKE;

ARTICLE; BLADDER CANCER; CANCER CELL; CLONAL EVOLUTION; DISEASE COURSE; DISTANT METASTASIS; DNA SEQUENCE; EXOME; GENE FREQUENCY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; METASTASIS; PILOT STUDY; PRIORITY JOURNAL; SOMATIC MUTATION; BIOLOGICAL MODEL; BLADDER TUMOR; GENETICS; METABOLISM; MUTAGENESIS; MUTATION; PATHOLOGY; PHYLOGENY; TIME FACTOR; UROTHELIUM;

APOBEC DEAMINASES; CLONAL EVOLUTION; DISEASE PROGRESSION; GENE FREQUENCY; HUMANS; MODELS, BIOLOGICAL; MUTAGENESIS; MUTATION; NEOPLASM METASTASIS; PHYLOGENY; SEQUENCE ANALYSIS, DNA; TIME FACTORS; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84994452815     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2016.08.003     Document Type: Article

References (35)

1. Babjuk, M., Burger, M., Zigeuner, R., Shariat, S.F., van Rhijn, B.W., Comperat, E., Sylvester, R.J., Kaasinen, E., Bohle, A., Palou Redorta, J., Roupret, M., EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur. Urol. 64 (2013), 639–653.
2. Burns, M.B., Lackey, L., Carpenter, M.A., Rathore, A., Land, A.M., Leonard, B., Refsland, E.W., Kotandeniya, D., Tretyakova, N., Nikas, J.B., Yee, D., Temiz, N.A., Donohue, D.E., McDougle, R.M., Brown, W.L., Law, E.K., Harris, R.S., APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 494 (2013), 366–370.
3. Cibulskis, K., Lawrence, M.S., Carter, S.L., Sivachenko, A., Jaffe, D., Sougnez, C., Gabriel, S., Meyerson, M., Lander, E.S., Getz, G., Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31 (2013), 213–219.
4. Cingolani, P., Platts, A., Wang le, L., Coon, M., Nguyen, T., Wang, L., Land, S.J., Lu, X., Ruden, D.M., A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly 6 (2012), 80–92.
5. de Bruin, E.C., McGranahan, N., Mitter, R., Salm, M., Wedge, D.C., Yates, L., Jamal-Hanjani, M., Shafi, S., Murugaesu, N., Rowan, A.J., Gronroos, E., Muhammad, M.A., Horswell, S., Gerlinger, M., Varela, I., Jones, D., Marshall, J., Voet, T., Van Loo, P., Rassl, D.M., Rintoul, R.C., Janes, S.M., Lee, S.M., Forster, M., Ahmad, T., Lawrence, D., Falzon, M., Capitanio, A., Harkins, T.T., Lee, C.C., Tom, W., Teefe, E., Chen, S.C., Begum, S., Rabinowitz, A., Phillimore, B., Spencer-Dene, B., Stamp, G., Szallasi, Z., Matthews, N., Stewart, A., Campbell, P., Swanton, C., Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science (New York, N.Y.) 346 (2014), 251–256.
6. DePristo, M.A., Banks, E., Poplin, R., Garimella, K.V., Maguire, J.R., Hartl, C., Philippakis, A.A., del Angel, G., Rivas, M.A., Hanna, M., McKenna, A., Fennell, T.J., Kernytsky, A.M., Sivachenko, A.Y., Cibulskis, K., Gabriel, S.B., Altshuler, D., Daly, M.J., A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43 (2011), 491–498.
7. Gerlinger, M., Horswell, S., Larkin, J., Rowan, A.J., Salm, M.P., Varela, I., Fisher, R., McGranahan, N., Matthews, N., Santos, C.R., Martinez, P., Phillimore, B., Begum, S., Rabinowitz, A., Spencer-Dene, B., Gulati, S., Bates, P.A., Stamp, G., Pickering, L., Gore, M., Nicol, D.L., Hazell, S., Futreal, P.A., Stewart, A., Swanton, C., Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat. Genet. 46 (2014), 225–233.
8. Gerlinger, M., Rowan, A.J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., Varela, I., Phillimore, B., Begum, S., McDonald, N.Q., Butler, A., Jones, D., Raine, K., Latimer, C., Santos, C.R., Nohadani, M., Eklund, A.C., Spencer-Dene, B., Clark, G., Pickering, L., Stamp, G., Gore, M., Szallasi, Z., Downward, J., Futreal, P.A., Swanton, C., Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. New Engl. J. Med. 366 (2012), 883–892.
9. Gonzalez-Perez, A., Perez-Llamas, C., Deu-Pons, J., Tamborero, D., Schroeder, M.P., Jene-Sanz, A., Santos, A., Lopez-Bigas, N., IntOGen-mutations identifies cancer drivers across tumor types. Nat. Methods 10 (2013), 1081–1082.
10. Griffith, M., Griffith, O.L., Coffman, A.C., Weible, J.V., McMichael, J.F., Spies, N.C., Koval, J., Das, I., Callaway, M.B., Eldred, J.M., Miller, C.A., Subramanian, J., Govindan, R., Kumar, R.D., Bose, R., Ding, L., Walker, J.R., Larson, D.E., Dooling, D.J., Smith, S.M., Ley, T.J., Mardis, E.R., Wilson, R.K., DGIdb: mining the druggable genome. Nat. Methods 10 (2013), 1209–1210.
11. Gupta, G.P., Massague, J., Cancer metastasis: building a framework. Cell 127 (2006), 679–695.
12. Hartmann, A., Rosner, U., Schlake, G., Dietmaier, W., Zaak, D., Hofstaedter, F., Knuechel, R., Clonality and genetic divergence in multifocal low-grade superficial urothelial carcinoma as determined by chromosome 9 and p53 deletion analysis. Lab. Invest. 80 (2000), 709–718.
13. Hedegaard, J., Lamy, P., Nordentoft, I., Algaba, F., Hoyer, S., Ulhoi, B.P., Vang, S., Reinert, T., Hermann, G.G., Mogensen, K., Thomsen, M.B., Nielsen, M.M., Marquez, M., Segersten, U., Aine, M., Hoglund, M., Birkenkamp-Demtroder, K., Fristrup, N., Borre, M., Hartmann, A., Stohr, R., Wach, S., Keck, B., Seitz, A.K., Nawroth, R., Maurer, T., Tulic, C., Simic, T., Junker, K., Horstmann, M., Harving, N., Petersen, A.C., Calle, M.L., Steyerberg, E.W., Beukers, W., van Kessel, K.E., Jensen, J.B., Pedersen, J.S., Malmstrom, P.U., Malats, N., Real, F.X., Zwarthoff, E.C., Orntoft, T.F., Dyrskjot, L., Comprehensive transcriptional analysis of early-stage urothelial carcinoma. Cancer Cell 30:1 (2016 Jul 11), 27–42, 10.1016/j.ccell.2016.05.004 [Epub 2016 Jun 16].
14. Hermans, T.J., Fransen van de Putte, E.E., Horenblas, S., Lemmens, V., Aben, K., van der Heijden, M.S., Beerepoot, L.V., Verhoeven, R.H., van Rhijn, B.W., Perioperative treatment and radical cystectomy for bladder cancer – a population based trend analysis of 10,338 patients in The Netherlands. Eur. J. Cancer 54 (2016), 18–26.
15. Hoglund, M., On the origin of syn- and metachronous urothelial carcinomas. Eur. Urol. 51 (2007), 1185–1193 discussion 1193.
16. Jordan, E.J., Iyer, G., Targeted therapy in advanced bladder cancer: what have we learned?. Urol. Clin. North Am. 42 (2015), 253–262 ix.
17. Kim, J., Akbani, R., Creighton, C.J., Lerner, S.P., Weinstein, J.N., Getz, G., Kwiatkowski, D.J., Invasive bladder cancer: genomic insights and therapeutic promise. Clin. Cancer Res. 21 (2015), 4514–4524.
18. Knowles, M.A., Hurst, C.D., Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat. Rev. Cancer 15 (2015), 25–41.
19. Law, V., Knox, C., Djoumbou, Y., Jewison, T., Guo, A.C., Liu, Y., Maciejewski, A., Arndt, D., Wilson, M., Neveu, V., Tang, A., Gabriel, G., Ly, C., Adamjee, S., Dame, Z.T., Han, B., Zhou, Y., Wishart, D.S., DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 42 (2014), D1091–D1097.
20. Li, H., Durbin, R., Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics (Oxford, England) 25 (2009), 1754–1760.
21. Ling, S., Hu, Z., Yang, Z., Yang, F., Li, Y., Lin, P., Chen, K., Dong, L., Cao, L., Tao, Y., Hao, L., Chen, Q., Gong, Q., Wu, D., Li, W., Zhao, W., Tian, X., Hao, C., Hungate, E.A., Catenacci, D.V., Hudson, R.R., Li, W.H., Lu, X., Wu, C.I., Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution. Proc. Natl. Acad. Sci. U. S. A 112 (2015), E6496–E6505.
22. Marusyk, A., Tabassum, D.P., Altrock, P.M., Almendro, V., Michor, F., Polyak, K., Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity. Nature 514 (2014), 54–58.
23. Nordentoft, I., Lamy, P., Birkenkamp-Demtroder, K., Shumansky, K., Vang, S., Hornshoj, H., Juul, M., Villesen, P., Hedegaard, J., Roth, A., Thorsen, K., Hoyer, S., Borre, M., Reinert, T., Fristrup, N., Dyrskjot, L., Shah, S., Pedersen, J.S., Orntoft, T.F., Mutational context and diverse clonal development in early and late bladder cancer. Cell Rep. 7 (2014), 1649–1663.
24. Roberts, S.A., Lawrence, M.S., Klimczak, L.J., Grimm, S.A., Fargo, D., Stojanov, P., Kiezun, A., Kryukov, G.V., Carter, S.L., Saksena, G., Harris, S., Shah, R.R., Resnick, M.A., Getz, G., Gordenin, D.A., An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat. Genet. 45 (2013), 970–976.
25. Rubio-Perez, C., Tamborero, D., Schroeder, M.P., Antolin, A.A., Deu-Pons, J., Perez-Llamas, C., Mestres, J., Gonzalez-Perez, A., Lopez-Bigas, N., In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities. Cancer Cell 27 (2015), 382–396.
26. Sottoriva, A., Kang, H., Ma, Z., Graham, T.A., Salomon, M.P., Zhao, J., Marjoram, P., Siegmund, K., Press, M.F., Shibata, D., Curtis, C., A Big Bang model of human colorectal tumor growth. Nat. Genet. 47 (2015), 209–216.
27. Swanton, C., Intratumor heterogeneity: evolution through space and time. Cancer Res. 72 (2012), 4875–4882.
28. Swanton, C., McGranahan, N., Starrett, G.J., Harris, R.S., APOBEC enzymes: mutagenic fuel for cancer evolution and heterogeneity. Cancer Discov. 5 (2015), 704–712.
29. TCGA, Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507 (2014), 315–322.
30. Vogelstein, B., Papadopoulos, N., Velculescu, V.E., Zhou, S., Diaz, L.A. Jr., Kinzler, K.W., Cancer genome landscapes. Science (New York, N.Y.) 339 (2013), 1546–1558.
31. von der Maase, H., Gemcitabine in transitional cell carcinoma of the urothelium. Expert Rev. Anticancer Ther. 3 (2003), 11–19.
32. Wishart, D.S., Knox, C., Guo, A.C., Shrivastava, S., Hassanali, M., Stothard, P., Chang, Z., Woolsey, J., DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 34 (2006), D668–D672.
33. Witjes, J.A., Comperat, E., Cowan, N.C., De Santis, M., Gakis, G., Lebret, T., Ribal, M.J., Van der Heijden, A.G., Sherif, A., EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur. Urol. 65 (2014), 778–792.
34. Yates, L.R., Gerstung, M., Knappskog, S., Desmedt, C., Gundem, G., Van Loo, P., Aas, T., Alexandrov, L.B., Larsimont, D., Davies, H., Li, Y., Ju, Y.S., Ramakrishna, M., Haugland, H.K., Lilleng, P.K., Nik-Zainal, S., McLaren, S., Butler, A., Martin, S., Glodzik, D., Menzies, A., Raine, K., Hinton, J., Jones, D., Mudie, L.J., Jiang, B., Vincent, D., Greene-Colozzi, A., Adnet, P.Y., Fatima, A., Maetens, M., Ignatiadis, M., Stratton, M.R., Sotiriou, C., Richardson, A.L., Lonning, P.E., Wedge, D.C., Campbell, P.J., Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat. Med. 21 (2015), 751–759.
35. Zhang, J., Fujimoto, J., Zhang, J., Wedge, D.C., Song, X., Zhang, J., Seth, S., Chow, C.W., Cao, Y., Gumbs, C., Gold, K.A., Kalhor, N., Little, L., Mahadeshwar, H., Moran, C., Protopopov, A., Sun, H., Tang, J., Wu, X., Ye, Y., William, W.N., Lee, J.J., Heymach, J.V., Hong, W.K., Swisher, S., Wistuba, II, Futreal, P.A., Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science (New York, N.Y.) 346 (2014), 256–259.